8/1/2025China’s Biotech Sector Faces Geopolitical Headwinds as Asia-Pacific E...

8/1/2025Wuxi AppTec Raises Nearly US$1B in Hong Kong to Fuel Global Expansion

8/1/2025India Moves to Set Minimum Import Prices to Protect Pharma Sector from...

7/31/2025China Seeks Feedback on Draft Guidelines for Eosinophilic Esophagitis ...

7/31/2025China Sees Surge in Drug Applications: 24 New Therapies Filed with NMP...

7/31/2025Lee’s Subsidiary Wins Approval of Socazolimab for ES‑SCLC in China

7/31/2025Alphamab's JSKN003 Wins Orphan and BTD Designations in Two Major Marke...

7/31/2025DarwinCell Breaks Ground with CNY 200M Series C Financing from Tsing C...

7/31/2025Ancocare Closes Series B Financing to Fuel Oncolytic Virus Pipeline E...

7/31/2025Leto Lab Secures Series D Financing Led by Hankang Capital

7/31/2025R&B Bio Secures New Funding Round Led by SBI Holdings

More>>

7/31/2025China's Plan to Boost Drug Coverage by Commercial Insurers No 'Magic W...

7/29/2025US Drug Supply Chain Exposure to China (Brookings)

7/23/2025Accelerating US Oncology Drug Development Using Chinese First-in-Human...

7/22/2025PharmaDJ's China Biopharma Tracker – June 2025 (PharmaDJ)

7/12/2025Analysing Key Trends In China's Patent-linkage System and Their Impact...

7/10/2025China's Rising Biotechnology Sector: Friend or Foe? (EGGI)

7/8/2025As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...

7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...

7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)

7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...

7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...

More>>